Tech Company Financing Transactions
ChromaTan Funding Round
National Institutes of Health participated in a $2 million venture round for ChromaTan. The round was announced on 5/31/2024.
Transaction Overview
Company Name
Announced On
5/31/2024
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for the development and integration of its novel BioRMB� single-use, column-free, steady-state continuous counter-current elution technology for manufacturing AAVs.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
3 Spring House Innovation Park 103
Lower Gwynedd, PA 19002
USA
Lower Gwynedd, PA 19002
USA
Phone
Website
Email Address
Overview
The future of single-use, column-free purification is here. We are dedicated to empowering biopharmaceutical manufacturers with our cutting-edge, columnless single-use continuous chromatography platform, offering enhanced flexibility, scalability, and purity, reducing downtime and resin consumption, and maximizing productivity for the cost-effective production of life-saving therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rajiv Datar
Chief Financial Officer
David Fogel
Chief Technical Officer
Oleg Shinkazh
VP - Engineering
Craig Pointer
VP - Human Resources
Yvonne Connolly
Browse more venture capital transactions:
Prev: 5/31/2024: Mavenir Systems venture capital transaction
Next: 5/31/2024: Euler Motors venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs